Acquirer(s)
- Zoetis Australia Research and Manufacturing Pty Ltd
Target(s)
- Betrola Investments Pty Ltd (including Jurox Pty Ltd)
Summary
Zoetis Australia Research and Manufacturing Pty Ltd, a wholly owned subsidiary of Zoetis Inc. (Zoetis), proposes to acquire Betrola Investments Pty Ltd, including its wholly owned subsidiary, Jurox Pty Ltd (Jurox) (the Proposed Acquisition).
Zoetis and Jurox both operate globally. In Australia, they are involved in the development, manufacture and marketing of animal health products for companion animals and livestock.
The ACCC commenced its public review of the Proposed Acquisition on 30 September 2021.
On 17 February 2022, the ACCC published a Statement of Issues outlining preliminary competition concerns in relation to the Proposed Acquisition.
On 11 August 2022, the ACCC commenced market consultation on a draft proposed section 87B undertaking.
On 15 September 2022, the ACCC decided to not oppose Zoetis' proposed acquisition of Jurox, subject to the ACCC accepting a court-enforceable undertaking from Zoetis to divest Jurox's teat sealant and intramammary antibiotic products.
Market definition
Refer to the Public Competition Assessment attached below.
Competition analysis
Refer to the Public Competition Assessment attached below.
Market inquiries
| Document title | Date | |
|---|---|---|
| Zoetis Jurox - Market inquiries letter |
Statement of issues
| Document title | Date | |
|---|---|---|
| Zoetis proposed acquisition of Jurox - Statement of Issues |
Public competition assessment
| Document title | Date | |
|---|---|---|
| Zoetis_Jurox - Public competition assessment |
Undertakings
| Document title | Date | |
|---|---|---|
| Zoetis Inc. - s87B undertaking - final signed PUBLIC VERSION - 13 September 2022 |
Timeline
| Date | Event |
|---|---|
ACCC commenced informal review under the Informal Merger Review Process Guidelines. |
|
Closing date for submissions. |
|
ACCC is awaiting information from the parties. Former provisional date for announcement of ACCC's findings (16 December) is delayed. |
|
ACCC received information from parties. |
|
ACCC is awaiting information from the parties. Former proposed date for announcement of ACCC's findings (3 February 2022) is delayed. |
|
ACCC received information from parties. |
|
ACCC published a Statement of Issues outlining preliminary competition concerns. |
|
Closing date for submissions relating to Statement of Issues. |
|
ACCC is awaiting information from the parties. Former proposed date for announcement of ACCC's findings (28 April) is delayed. |
|
ACCC commenced market consultation on proposed s87B undertaking. |
|
Closing date for submissions relating to the proposed s87B undertaking. |
|
ACCC announced it would not oppose the proposed acquisition, subject to a section 87B undertaking accepted by the ACCC. |